Doing bespoke work since 2002....., Custom Products Group

Patrick Hansen

Doing bespoke work since 2002.....

Custom Products Group

Custom Products was started 14 years ago at Lehman Brothers by current co-founder Patrick Hansen, CFA. After 3 years at Lehman, Patrick moved the team to Macquarie Securities where Simon Rigney (co-founder) joined. 3 years ago we took Custom Products independent. 

Our core strength can be summed up three words. 1- Customization - we have very little off the shelf products and most work is done on a one on one bespoke basis. 2- Speed - We pride ourselves in our ability to get requests back to the client very quickly. 3- Confidentiality - We do not redistribute. There is no grace period where we wait a week and then mass blast. Any request stops with that client.

Thematic (Sector/Industry)

It has been a while since we updated the "Hated by the Street" screen. So we thought it would be good to see which names made the list. Usually we only screen for names where the % of BUY recommendations to Total is less than 20%. However, 126 names made that list. We therefore further limited the screen by adding % of SELL recommendations greater than 30% of total recommendations. 26 names met both criteria. At the top of the list is <a href="https://www.smartkarma.com/entities/391" target="_blank" data-smartkarma-citation="entities:391:1">Sharp Corp (6753 JP)</a> with 0 BUY recommendations and 8 SELL…

It has been a while since we updated the "Hated by the Street" screen. So we thought it would be good to see which names made the list. Usually we only screen for names where the % of BUY recommendations to Total is less than 20%. However, 126 names made that list. We therefore further limited the screen by adding % of SELL recommendations greater than 30% of total recommendations. 26 names met both criteria. At the top of the list is Sharp Corp (6753 JP) with 0 BUY recommendations and 8 SELL…

Names that Are Hated and Loved by the Street in Japan....

Leading Independent Investment Research, Morningstar, Inc.

Morningstar

Leading Independent Investment Research

Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. We offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors. 

Morningstar provides data on more than 500,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 16 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries, with more than $180 billion in assets under advisement or management as of June 30, 2015. We have operations in 27 countries.

Download the Morningstar Fact Sheet : http://corporate.morningstar.com/US/documents/MarketingFactSheets/AboutMorningstarFactsheet.pdf

Equity Bottom-Up

Kobayashi Pharmaceutical Co / Equity Bottom-Up

We initiate a niche consumer product play <a href="https://www.smartkarma.com/entities/14930" target="_blank" data-smartkarma-citation="entities:14930:1">Kobayashi Pharmaceutical Co (4967 JP)</a> with a fair value estimate of JPY 6,900. We assign the company a narrow-moat rating, underpinned by the company’s intangible asset of an entrenched retailer relationship in Japan. Although we like the firm’s niche strategy and relatively attractive margin among the consumer names in Japan, the stock has outperformed Topix over the past two years, and now trades at 6% premium to our fair value estimate. It seems the…

We initiate a niche consumer product play Kobayashi Pharmaceutical Co (4967 JP) with a fair value estimate of JPY 6,900. We assign the company a narrow-moat rating, underpinned by the company’s intangible asset of an entrenched retailer relationship in Japan. Although we like the firm’s niche strategy and relatively attractive margin among the consumer names in Japan, the stock has outperformed Topix over the past two years, and now trades at 6% premium to our fair value estimate. It seems the…

Initiating Coverage of Kobayashi Pharmaceutical With JPY 6,900 FVE and Narrow-Moat Rating

We recently published a piece looking at Sectors that are highly correlated to TOPIX. In the piece, we highlight the other side. Sectors that are not correlated to TOPIX. Now when we get into the smaller-cap space, the correlations to TOPIX tend to be lower. We therefore limited the universe to names above ¥200bn mkt-cap. Food &amp; Staples Retailing is one of the sectors with a pretty low correlation to TOPIX. While, the two largest names by mkt-cap, <a href="https://www.smartkarma.com/entities/1041" target="_blank" data-smartkarma-citation="entities:1041:1">Seven &amp; I Holdings Co Ltd (3382 JP)</a> and <a href="https://www.smartkarma.com/entities/3" target="_blank" data-smartkarma-citation="entities:3:1">Aeon Co</a>…

We recently published a piece looking at Sectors that are highly correlated to TOPIX. In the piece, we highlight the other side. Sectors that are not correlated to TOPIX. Now when we get into the smaller-cap space, the correlations to TOPIX tend to be lower. We therefore limited the universe to names above ¥200bn mkt-cap. Food &amp; Staples Retailing is one of the sectors with a pretty low correlation to TOPIX. While, the two largest names by mkt-cap, Seven &amp; I Holdings Co Ltd (3382 JP) and Aeon Co…

Sectors Not Correlated to TOPIX - Retailing, Food & Staples Retailing, and Utilities

With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of the year. We screened for names that 1- have a success rate since 2000 greater than 70%. 2- median return relative to TOPIX is greater than 5.5%.<h2>Screen Results</h2><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/031/654/original/2.png?1502826967" class="editor-image img-responsive" data-smartkarma-image-id="31654"></figure><div class="content-caption">Source: Custom Products</div>Both <a href="https://www.smartkarma.com/entities/12795" target="_blank" data-smartkarma-citation="entities:12795:1">Yokogawa Electric Corp (6841 JP)</a> and <a href="https://www.smartkarma.com/entities/14085" target="_blank" data-smartkarma-citation="entities:14085:1">Sapporo Holdings Ltd (2501 JP)</a> have been up 88% of the time. That means in the 17 years they have only been down twice relative to…

With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of the year. We screened for names that 1- have a success rate since 2000 greater than 70%. 2- median return relative to TOPIX is greater than 5.5%.Screen ResultsSource: Custom ProductsBoth Yokogawa Electric Corp (6841 JP) and Sapporo Holdings Ltd (2501 JP) have been up 88% of the time. That means in the 17 years they have only been down twice relative to…

Which Names Do the Best from September to the End of the Year....

Fintech, Real-time Big-Data Analytics Provider, Nowcast, Inc.

Ryota Hayashi

Fintech, Real-time Big-Data Analytics Provider

Nowcast, Inc.

We at Nowcast develop "Big-Data Economic Analytics Platforms".  We aim to revolutionize the financial markets by providing "accurate" and "real-time" analytics based on economic indicators and corporate activity data procured worldwide. 

Our Main Services

(1) Real-time Analytics
With our Nikkei CPI Now Index at our core, we provide real time analytics of global economic indicators such as POS Data. By utilizing Big-Data technology, we also provide real-time analytics of micro level data such as corporate earnings. 

(2) Big-Data Application Consulting
We too provide business consultation and conduct joint research on initiatives that strive to use data, such as from the operation capacity of construction machinery to number of passengers on railroad trains, as economic indicators. We provide continuous support to Data Scientists specialized in economics in their proposal stage, product development and up till its business development. 

(3) Monetary Policy Insights
With the proactive involvement of and support from from academicians in macroeconomics & key figures in the financial industry, we produce reports, conduct seminars and meetings that discuss about the forecast of financial markets, provide intellectual suggestions on asset allocation, etc. 

Macroeconomics

<ul class="ember-tether-target ember-tether-element-attached-top ember-tether-element-attached-left ember-tether-target-attached-top ember-tether-target-attached-right"><li>"Nikkei CPINow" is a statistical database produced by Nowcast Inc. that provides real-time economic statistics using so-called “big data” gathered on a real-time basis; making it possible to “nowcast” economic developments, that is, to gauge them almost in real time.</li><li>Nikkei CPINow was launched in January 2016, disseminating the new “CPINow” price indeces, which succeeds and improves upon the Nikkei UTokyo Daily Price Index.</li><li>This December 2016 Review looks into analyzing the current developments in Japan's economy based on The Nikkei CPINow S index &amp; T index.</li></ul>

"Nikkei CPINow" is a statistical database produced by Nowcast Inc. that provides real-time economic statistics using so-called “big data” gathered on a real-time basis; making it possible to “nowcast” economic developments, that is, to gauge them almost in real time.Nikkei CPINow was launched in January 2016, disseminating the new “CPINow” price indeces, which succeeds and improves upon the Nikkei UTokyo Daily Price Index.This December 2016 Review looks into analyzing the current developments in Japan's economy based on The Nikkei CPINow S index &amp; T index.

December 2016 Review of Current Developments in Japan's Economy

Japan

KOBAYASHI PHARMACEUTICAL CO., LTD. manufactures and wholesales pharmaceuticals and medical equipment.  The Company also develops and manufactures fragrances, deodorant, sanitary products, and ointment for stiff shoulders, as well as exports to Southeast Asia and the US.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kobayashi Pharmaceutical Co (4967 JP)

Names that Are Hated and Loved by the Street in Japan....

It has been a while since we updated the "Hated by the Street" screen. So we thought it would be good to see which names made the list. Usually we...

Custom Products Group

Initiating Coverage of Kobayashi Pharmaceutical With JPY 6,900 FVE and Narrow-Moat Rating

We initiate a niche consumer product play Kobayashi Pharmaceutical Co (4967 JP) with a fair value estimate of JPY 6,900. We assign the company a...

Morningstar, Inc.

Sectors Not Correlated to TOPIX - Retailing, Food & Staples Retailing, and Utilities

We recently published a piece looking at Sectors that are highly correlated to TOPIX. In the piece, we highlight the other side. Sectors that are...

Custom Products Group

Which Names Do the Best from September to the End of the Year....

With only 2 weeks left in August, we wanted to highlight names that you should be looking at heading into the next couple of months to the end of...

Custom Products Group

December 2016 Review of Current Developments in Japan's Economy

"Nikkei CPINow" is a statistical database produced by Nowcast Inc. that provides real-time economic statistics using so-called “big data”...

Nowcast, Inc.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)